CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements.

Claudio-Campos KI, Gonz?lez-Santiago P, Renta JY, Rodr?guez J, Carrasquillo K, Gaedigk A, Roche A, Ducong? J. CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements. Pharmacogenomics. 2019 01; 20(1):3-8.

View in: PubMed

subject areas

Aged
Anticoagulants
Genotype
Humans
Male
Mutation, Missense
Pharmacogenetics
Warfarin

authors with profiles

Jorge Duconge

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support